Rankings
▼
Calendar
XNCR Q4 2016 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena
XNCR
Xencor, Inc.
$861M
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$6M
Gross Profit
-$7M
-107.5% margin
Operating Income
-$10M
-155.7% margin
Net Income
-$9M
-140.8% margin
EPS (Diluted)
$-0.21
QoQ Revenue Growth
-17.7%
Cash Flow
Operating Cash Flow
-$16M
Free Cash Flow
-$16M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$429M
Total Liabilities
$115M
Stockholders' Equity
$314M
Cash & Equivalents
$15M
← FY 2016
All Quarters
Q1 2017 →